Articles From: 2014/11/17 - Dynex Capital, Inc. to Present at the Southwest IDEAS Investor Conference to 2014/11/15 - AMERICAN REALTY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against American Realty Capital Properties, Inc. -- ARCP


2014/11/17
Dynex Capital, Inc. (NYSE: DX) announced today that Stephen J.
Sign-up for 2014/11/17 - Dynex Capital, Inc. to Present at the Southwest IDEAS Investor Conference investment picks
2014/11/17
Energy Transfer Partners, L.P. ( NYSE: ETP ) and Regency Energy Partners LP ( NYSE:RGP ) today announced that their joint venture, Lone Star NGL LLC (“Lone Star”), has Board of Directors approval to construct a 533 mile, 24 and 30-inch natural gas liquids (NGL) pipeline from the Permian Basin to Mont Belvieu, Texas, and convert Lone Star’s existing West Texas 12-inch NGL pipeline into crude oil/condensate service.
Sign-up for 2014/11/17 - Energy Transfer Partners and Regency Energy Partners to Construct Large Diameter NGL Pipeline from Permian Basin to Mont Belvieu investment picks
2014/11/17
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Valley Financial Corporation (“Valley Financial”) (NasdaqCM: VYFC) concerning the acquisition by BNC Bancorp.
Sign-up for 2014/11/17 - VALLEY FINANCIAL SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by BNC Bancorp investment picks
2014/11/17
MetLife, Inc. (NYSE:MET) today announced that it had completed the mergers of its subsidiaries MetLife Insurance Company of Connecticut, MetLife Investors USA Insurance Company, MetLife Investors Insurance Company and Exeter Reassurance Company Limited.
Sign-up for 2014/11/17 - Metlife Completes Merger of Three Life Insurance Companies and One Former Offshore Reinsurance Subsidiary investment picks
2014/11/17
Levi & Korsinsky is investigating the Board of Directors of Allergan Inc. (“Allergan” or “the Company”) (NYSE: AGN) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Actavis plc.
Sign-up for 2014/11/17 - AGN INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc investment picks
2014/11/17
Lannett Company, Inc. (NYSE: LCI) today announced that Ernest J.
Sign-up for 2014/11/17 - Lannett Announces Retirement of Executive Officer investment picks
2014/11/17
Splunk Inc. (NASDAQ:SPLK), provider of the leading software platform for real-time Operational Intelligence, today announced the appointment of Rick Fitz as vice president of IT Markets.
Sign-up for 2014/11/17 - Rick Fitz Joins Splunk as Vice President of IT Markets investment picks
2014/11/17
THE WOODLANDS, Texas, Nov.
Sign-up for 2014/11/17 - LGI Homes, Inc. Announces Offering of $75,000,000 of Convertible Notes Due 2019 investment picks
2014/11/17
BATON ROUGE, La.
Sign-up for 2014/11/17 - Albemarle awarded Diamond Award by Arkansas Environmental Federation investment picks
2014/11/17
http://media3.marketwire.com/logos/20130903-JustE.jpg TORONTO, ONTARIO --
Sign-up for 2014/11/17 - Clearance Received for the Sale of National Home Services by Just Energy Group Inc. to Reliance Comfort Limited Partnership investment picks
2014/11/17
http://www.ccnmatthews.com/logos/20110120-zargon_200.jpg CALGARY, ALBERTA --
Sign-up for 2014/11/17 - Zargon Oil & Gas Ltd. Confirms November 2014 Cash Dividend investment picks
2014/11/17
BROOMFIELD, Colo.
Sign-up for 2014/11/17 - Level 3 Announces Proposed Private Offering of Senior Notes investment picks
2014/11/17
50,000 BPD Corpus Christi, Texas, project slated to be operational in second half of 2016 RESTON, Va.
Sign-up for 2014/11/17 - Leidos Wins Contract to Design, Build Magellan Midstream Partners Condensate Splitter investment picks
2014/11/16
By Daniel Gilbert HOUSTON --
Sign-up for 2014/11/16 - Investigators to probe DuPont's deadly Texas chemical leak investment picks
2014/11/16
By Qu Yunxu BEIJING (Caixin Online) -- Alibaba Group Holding Ltd.'s (BABA) annual e-commerce frenzy smashed last year's record, but company executives were not exactly ecstatic.
Sign-up for 2014/11/16 - Alibaba and the truth behind the Singles Day sales numbers investment picks
2014/11/16
Includes partnership to expand commercialization of aerospace composites Longtime Boeing supplier rewarded for commitment to Partnering for Success TOKYO , Nov.
Sign-up for 2014/11/16 - Boeing, Toray Industries Reach Agreement on Composites for 777X Wings investment picks
2014/11/16
AUSTIN, Texas , Nov.
Sign-up for 2014/11/16 - Hanger Postpones Release of Third Quarter 2014 Financial Results investment picks
2014/11/16
By Mark Hulbert, MarketWatch Money managers tend to make major changes around the beginning of the year CHAPEL HILL, N.C. (MarketWatch) -- Don't sell any of your large-cap stocks, and don't buy any small-caps.
Sign-up for 2014/11/16 - UPDATE: Why you should favor large-cap stocks for the next six weeks investment picks
2014/11/16
-Only Rentrak Provides the Official Global Movie Results- LOS ANGELES , Nov.
Sign-up for 2014/11/16 - Rentrak Announces Official Worldwide Box Office Results for Weekend of November 16, 2014 investment picks
2014/11/16
Botox maker Allergan Inc. (AGN) and Irish pharmaceutical company Actavis PLC (ACT) are close to a friendly deal, which could be announced as early as Monday, the Wall Street Journal reported Sunday.
Sign-up for 2014/11/16 - Allergan, Actavis near cash-and-stock deal: WSJ investment picks
2014/11/16
The Medicines Company (NASDAQ:MDCO) today presented findings from a new Phase 1 study showing that a single infusion of MDCO-216, an investigational lipid-modifying agent, in both healthy and CAD patients, modified key lipid parameters including ApoA-1, phospholipids, HDL, pre-beta 1 HDL and Apo E, markedly increased ABCA1 mediated efflux, a potential marker of reverse cholesterol transport and was well tolerated.
Sign-up for 2014/11/16 - The Medicines Company Presents New Phase 1 Data Showing Investigational Agent MDCO-216 Modified Key Lipid Parameters and Was Well-Tolerated in Healthy and Coronary Artery Disease (CAD) Patients investment picks
2014/11/16
AstraZeneca (NYSE: AZN) today presented top-line results of two pivotal Phase III trials investigating the potential of lesinurad, a selective uric acid re-absorption inhibitor (SURI), when used in combination with xanthine oxidase (XO) inhibitor allopurinol.
Sign-up for 2014/11/16 - AstraZeneca Presents Data from Phase III Studies of Lesinurad in Combination with Allopurinol in Gout Patients at American College of Rheumatology 2014 Annual Meeting investment picks
2014/11/16
Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for three students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation’s premier research competition for high school students.
Sign-up for 2014/11/16 - Arizona and New Mexico High School Scientists Win Regional Siemens Competition at the University of Texas at Austin for Research on Intrinsically Disordered Proteins for Drug Discovery and Computational Models of Tree Growth investment picks
2014/11/16
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trading in Monday's session are Tyson Foods Inc., Urban Outfitters Inc. and Agilent Technologies Inc. Tyson Foods (TSN) is projected to post fiscal fourth-quarter earnings of 76 cents a share, according to a consensus survey by FactSet.
Sign-up for 2014/11/16 - UPDATE: Tyson, Urban Outfitters, Agilent earnings in focus investment picks
2014/11/16
By Wallace Witkowski, MarketWatch Home Depot, Lowe's, Target report results SAN FRANCISCO (MarketWatch) -- Earnings season wraps up this week as the last Dow component and most of the remaining S&P 500 companies report.
Sign-up for 2014/11/16 - UPDATE: Retailers close out earnings season investment picks
2014/11/16
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that a pre-specified analysis of investigational data from a pivotal Phase 2 study (KEYNOTE-002) showed KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, substantially improved the primary endpoint of progression-free survival (PFS, as assessed by RECIST 1.1, independent central review) (HR 0.57 and 0.50 for 2 mg/kg and 10 mg/kg every three week doses, respectively), compared to chemotherapy (P<0.0001 for both comparisons) in patients with ipilimumab-refractory advanced melanoma (n=540). At six months, the PFS rates for KEYTRUDA were 34 percent at the 2 mg/kg dose (95% CI, 27-41) (n=180) and 38 percent at the 10 mg/kg dose (95% CI, 31-45) (n=181), compared to 16 percent for chemotherapy (95% CI, 10-22) (n=179). The median duration of follow-up at the interim analysis was 10 months.
Sign-up for 2014/11/16 - Merck Announces Positive Study Investigating the Use of KEYTRUDA® (pembrolizumab) Compared to Chemotherapy in Patients with Ipilimumab-Refractory Advanced Melanoma investment picks
2014/11/16
Exelixis, Inc. (NASDAQ:EXEL) today announced preliminary results from a phase 1 investigator-sponsored trial (IST) evaluating the safety and activity of XL888, an Exelixis-discovered small molecule oral inhibitor of Heat Shock Protein 90 (HSP90), in combination with vemurafenib in patients with unresectable stage III/IV BRAF V600 mutation-positive melanoma.
Sign-up for 2014/11/16 - Exelixis Announces Positive Preliminary Data From an Investigator-Sponsored Phase 1 Trial of XL888 and Vemurafenib investment picks
2014/11/16
Bristol-Myers Squibb Company (NYSE:BMY) today announced results from CheckMate -066, a Phase 3 randomized double blind study, comparing Opdivo , an investigational PD-1 immune checkpoint inhibitor, to the chemotherapy dacarbazine (DTIC) in patients with treatment naïve BRAF wild-type advanced melanoma (n=418). The study met the primary endpoint of overall survival (OS) with the median OS not reached for Opdivo vs.
Sign-up for 2014/11/16 - Study Comparing Opdivo (nivolumab) to Chemotherapy in Treatment Naïve Advanced Melanoma Patients Marks First PD-1 Immune Checkpoint Inhibitor to Demonstrate a Survival Benefit in a Phase 3 Trial investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: 2014/11/17 - Dynex Capital, Inc. to Present at the Southwest IDEAS Investor Conference to 2014/11/15 - AMERICAN REALTY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against American Realty Capital Properties, Inc. -- ARCP
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent